Dysregulation of plasmalogen homeostasis impairs cholesterol biosynthesis

Journal of Biological Chemistry

Volumn 290, Issue 48, 2015, Pages 28822-28833

  Honsho, Masanori ^a   Abe, Yuichi ^a   Fujiki, Yukio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; PHOSPHOLIPIDS; PHYSIOLOGY; SYNTHESIS (CHEMICAL);

CELLULAR LEVELS; CHOLESTEROL LEVELS; CHOLESTEROL SYNTHESIS; MONOOXYGENASES; PLASMALOGENS;

CHOLESTEROL;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LANOSTEROL SYNTHASE; MEMBRANE ASSOCIATED RING FINGER 6; PEROXIN 19; PLASMALOGEN; RAB PROTEIN; RING FINGER PROTEIN; SQUALENE MONOOXYGENASE; UNCLASSIFIED DRUG; CHOLESTEROL; MEMBRANE PROTEIN; PEX19 PROTEIN, HUMAN;

ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYCLIZATION; DOWN REGULATION; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENZYMATIC DEGRADATION; EPOXIDATION; FARNESYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIPOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN PRENYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; ANIMAL; BIOSYNTHESIS; CHO CELL LINE; CRICETULUS; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; HEK293 CELL LINE; HELA CELL LINE; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

ANIMALS; CHO CELLS; CHOLESTEROL; CRICETINAE; CRICETULUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HELA CELLS; HOMEOSTASIS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MEMBRANE PROTEINS; PLASMALOGENS; PROTEIN PRENYLATION; RAB GTP-BINDING PROTEINS; SQUALENE MONOOXYGENASE;

EID: 84948469149     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.656983     Document Type: Article

References (75)

1. Steinberg, S. J., Dodt, G., Raymond, G. V., Braverman, N. E., Moser, A. B., and Moser, H. W. (2006) Peroxisome biogenesis disorders. Biochim. Biophys. Acta 1763, 1733-1748
2. Braverman, N. E., and Moser, A. B. (2012) Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 1822, 1442-1452
3. Munn, N. J., Arnio, E., Liu, D., Zoeller, R. A., and Liscum, L. (2003) Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J. Lipid Res. 44, 182-192
4. Teigler, A., Komljenovic, D., Draguhn, A., Gorgas, K., and Just, W. W. (2009) Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum. Hum. Mol. Genet. 18, 1897-1908
5. Cheng, J. B., and Russell, D. W. (2004) Mammalian wax biosynthesis. I. identification of two fatty acyl-coenzyme a reductases with different substrate specificities and tissue distributions. J. Biol. Chem. 279, 37789-37797
6. Honsho, M., Asaoku, S., and Fujiki, Y. (2010) Posttranslational regulation of fatty acyl-CoA reductase 1, Far1, controls ether glycerophospholipid synthesis. J. Biol. Chem. 285, 8537-8542
7. Honsho, M., Asaoku, S., Fukumoto, K., and Fujiki, Y. (2013) Topogenesis and homeostasis of fatty acyl-CoA reductase 1. J. Biol. Chem. 288, 34588-34598
8. Buchert, R., Tawamie, H., Smith, C., Uebe, S., Innes, A. M., Al Hallak, B., Ekici, A. B., Sticht, H., Schwarze, B., Lamont, R. E., Parboosingh, J. S., Bernier, F. P., and Abou Jamra, R. (2014) A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am. J. Hum. Genet. 95, 602-610
9. Burg, J. S., and Espenshade, P. J. (2011) Regulation ofHMG-CoAreductase in mammals and yeast. Prog. Lipid Res. 50, 403-410
10. Hidaka, Y., Satoh, T., and Kamei, T. (1990) Regulation of squalene epoxidase in HepG2 cells. J. Lipid Res. 31, 2087-2094
11. Gonzalez, R., Carlson, J. P., and Dempsey, M. E. (1979) Two major regulatory steps in cholesterol synthesis by human renal cancer cells. Arch. Biochem. Biophys. 196, 574-580
12. Gill, S., Stevenson, J., Kristiana, I., and Brown, A. J. (2011) Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab. 13, 260-273
13. Honsho, M., Yagita, Y., Kinoshita, N., and Fujiki, Y. (2008) Isolation and characterization of mutant animal cell line defective in alkyl-dihydroxyacetonephosphate synthase: Localization and transport of plasmalogens to post-Golgi compartments. Biochim. Biophys. Acta 1783, 1857-1865
14. Okumoto, K., Bogaki, A., Tateishi, K., Tsukamoto, T., Osumi, T., Shimozawa, N., Suzuki, Y., Orii, T., and Fujiki, Y. (1997) Isolation and characterization of peroxisome-deficient Chinese hamster ovary cell mutants representing human complementation group III. Exp. Cell Res. 233, 11-20
15. Klein, U., Gimpl, G., and Fahrenholz, F. (1995) Alteration of the myometrial plasma membrane cholesterol content with -cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34, 13784-13793
16. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
17. Abe, Y., Honsho, M., Nakanishi, H., Taguchi, R., and Fujiki, Y. (2014) Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency. Biochim. Biophys. Acta 1841, 610-619
18. Matsuzono, Y., Kinoshita, N., Tamura, S., Shimozawa, N., Hamasaki, M., Ghaedi, K., Wanders, R. J. A., Suzuki, Y., Kondo, N., and Fujiki, Y. (1999) Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc. Natl. Acad. Sci. U.S.A. 96, 2116-2121
19. Ghaedi, K., Honsho, M., Shimozawa, N., Suzuki, Y., Kondo, N., and Fujiki, Y. (2000) PEX3 is the causal gene responsible for peroxisome membrane assembly defective Zellweger syndrome of complementation group G. Am. J. Hum. Genet. 67, 976-981
20. Miyata, N., and Fujiki, Y. (2005) Shuttling mechanism of peroxisome targeting signal type 1 receptor Pex5: ATP-independent import and ATP-dependent export. Mol. Cell. Biol. 25, 10822-10832
21. Honsho, M., Tamura, S., Shimozawa, N., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am. J. Hum. Genet. 63, 1622-1630
22. Okumoto, K., Itoh, R., Shimozawa, N., Suzuki, Y., Tamura, S., Kondo, N., and Fujiki, Y. (1998) Mutation in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum. Mol. Genet. 7, 1399-1405
23. Wong, J., Quinn, C. M., and Brown, A. J. (2006) SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J. 400, 485-491
24. Wang, B. T., Ducker, G. S., Barczak, A. J., Barbeau, R., Erle, D. J., and Shokat, K. M. (2011) The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. Proc. Natl. Acad. Sci. U.S.A. 108, 15201-15206
25. Du, X., Kristiana, I., Wong, J., and Brown, A. J. (2006) Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol. Biol. Cell 17, 2735-2745
26. James, G. L., Goldstein, J. L., Pathak, R. K., Anderson, R. G. W., and Brown, M. S. (1994) PxF, a prenylated protein of peroxisomes. J. Biol. Chem. 269, 14182-14190
27. Kinsella, B. T., and Maltese, W. A. (1992) rab GTP-binding proteins with three different carboxyl-terminal cysteine motifs are modified in vivo by 20-carbon isoprenoids. J. Biol. Chem. 267, 3940-3945
28. Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., and Landreth, G. (2007) Statins reduce amyloid- production through inhibition of protein isoprenylation. J. Biol. Chem. 282, 26832-26844
29. Gill, S., Chow, R., and Brown, A. J. (2008) Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 47, 391-404
30. Morand, O. H., Aebi, J. D., Dehmlow, H., Ji, Y. H., Gains, N., Lengsfeld, H., and Himber, J. (1997) Ro 48-8071, a new 2,3-oxidosqualene: lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin. J. Lipid Res. 38, 373-390
31. Dang, H., Liu, Y., Pang, W., Li, C., Wang, N., Shyy, J. Y., and Zhu, Y. (2009) Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-mediated improvement of hepatic lipid profile. J. Biol. Chem. 284, 6218-6226
32. Zelcer, N., Sharpe, L. J., Loregger, A., Kristiana, I., Cook, E. C. L., Phan, L., Stevenson, J., and Brown, A. J. (2014) The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway. Mol. Cell. Biol. 34, 1262-1270
33. Foresti, O., Ruggiano, A., Hannibal-Bach, H. K., Ejsing, C. S., and Carvalho, P. (2013) Sterol homeostasis requires regulated degradation of squalene monooxygenase by the ubiquitin ligase Doa10/Teb4. eLife 2, e00953
34. Hassink, G., Kikkert, M., van Voorden, S., Lee, S. J., Spaapen, R., van Laar, T., Coleman, C. S., Bartee, E., Früh, K., Chau, V., and Wiertz, E. (2005) TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem. J. 388, 647-655
35. Wong, J., Quinn, C. M., and Brown, A. J. (2007) Synthesis of the oxysterol, 24(S), 25-epoxycholesterol, parallels cholesterol production and may protect against cellular accumulation of newly-synthesized cholesterol. Lipids Health Dis. 6, 10
36. Sharpe, L. J., and Brown, A. J. (2013) Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR). J. Biol. Chem. 288, 18707-18715
37. Rizzo, W. B., Craft, D. A., Judd, L. L., Moser, H. W., and Moser, A. B. (1993) Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata. Biochem. Med. Metab. Biol. 50, 93-102
38. Zerenturk, E. J., Sharpe, L. J., and Brown, A. J. (2012) Sterols regulate 3-hydroxysterol -24-reductase (DHCR24) via dual sterol regulatory elements: cooperative induction of key enzymes in lipid synthesis by sterol regulatory element binding proteins. Biochim. Biophys. Acta 1821, 1350-1360
39. Goldstein, J. L., DeBose-Boyd, R. A., and Brown, M. S. (2006) Protein sensors for membrane sterols. Cell 124, 35-46
40. Sato, R. (2010) Sterol metabolism and SREBP activation. Arch. Biochem. Biophys. 501, 177-181
41. Nagase, T., Ishikawa, K., Miyajima, N., Tanaka, A., Kotani, H., Nomura, N., and Ohara, O. (1998) Prediction of the coding sequences of unidentified human genes: IX. the complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res. 5, 31-39
42. Zavacki, A. M., Arrojo E Drigo, R., Freitas, B. C. G., Chung, M., Harney, J. W., Egri, P., Wittmann, G., Fekete, C., Gereben, B., and Bianco, A. C. (2009) The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase. Mol. Cell. Biol. 29, 5339-5347
43. Sharpe, L. J., Cook, E. C. L., Zelcer, N., and Brown, A. J. (2014) The UPS and downs of cholesterol homeostasis. Trends Biochem. Sci. 39, 527-535
44. Doblas, V. G., Amorim-Silva, V., Posé, D., Rosado, A., Esteban, A., Arró, M., Azevedo, H., Bombarely, A., Borsani, O., Valpuesta, V., Ferrer, A., Tavares, R. M., and Botella, M. A. (2013) The SUD1 gene encodes a putative E3 ubiquitin ligase and is a positive regulator of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in Arabidopsis. Plant Cell 25, 728-743
45. Mangold, H. K., and Weber, N. (1987) Biosynthesis and biotransformation of ether lipids. Lipids 22, 789-799
46. Jollow, D., Kellerman, G. M., and Linnane, A. W. (1968) The biogenesis of mitochondria: III. the lipid composition of aerobically and anaerobically grown Saccharomyces cerevisiae as related to the membrane systems of the cells. J. Cell Biol. 37, 221-230
47. Nagumo, A., Kamei, T., Sakakibara, J., and Ono, T. (1995) Purification and characterization of recombinant squalene epoxidase. J. Lipid Res. 36, 1489-1497
48. Hidaka, Y., Hotta, H., Nagata, Y., Iwasawa, Y., Horie, M., and Kamei, T. (1991) Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in HepG2 cells. J. Biol. Chem. 266, 13171-13177
49. Sawada, M., Matsuo, M., Hagihara, H., Tenda, N., Nagayoshi, A., Okumura, H., Washizuka, K., Seki, J., and Goto, T. (2001) Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells. Eur. J. Pharmacol. 431, 11-16
50. Chan, P., Tomlinson, B., Lee, C. B., and Lee, Y. S. (1996) Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia. J. Clin. Pharmacol. 36, 422-427
51. Brown, M. S., Dana, S. E., and Goldstein, J. L. (1973) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 70, 2162-2166
52. Hodge, V. J., Gould, S. J., Subramani, S., Moser, H. W., and Krisans, S. K. (1991) Normal cholesterol synthesis in human cells requires functional peroxisomes. Biochem. Biophys. Res. Commun. 181, 537-541
53. Kovacs, W. J., Shackelford, J. E., Tape, K. N., Richards, M. J., Faust, P. L., Fliesler, S. J., and Krisans, S. K. (2004) Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model. Mol. Cell. Biol. 24, 1-13
54. Kovacs, W. J., Tape, K. N., Shackelford, J. E., Wikander, T. M., Richards, M. J., Fliesler, S. J., Krisans, S. K., and Faust, P. L. (2009) Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress. J. Biol. Chem. 284, 7232-7245
55. Faust, P. L., and Kovacs, W. J. (2014) Cholesterol biosynthesis and ER stress in peroxisome deficiency. Biochimie 98, 75-85
56. Vanhorebeek, I., Baes, M., and Declercq, P. E. (2001) Isoprenoid biosynthesis is not compromised in a Zellweger syndrome mouse model. Biochim. Biophys. Acta 1532, 28-36
57. Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., and Goldstein, J. L. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. U.S.A. 100, 12027-12032
58. Astruc, M., Tabacik, C., Descomps, B., and de Paulet, A. C. (1977) Squalene epoxidase and oxidosqualene lanosterol-cyclase activities in cholesterogenic and non-cholesterogenic tissues. Biochim. Biophys. Acta 487, 204-211
59. Wu, L. C., Pfeiffer, D. R., Calhoon, E. A., Madiai, F., Marcucci, G., Liu, S., and Jurkowitz, M. S. (2011) Purification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogen. J. Biol. Chem. 286, 24916-24930
60. Zerenturk, E. J., Kristiana, I., Gill, S., and Brown, A. J. (2012) The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1). Biochim. Biophys. Acta 1821, 1269-1277
61. Brown, A. J. (2009) 24(S),25-Epoxycholesterol: a messenger for cholesterol homeostasis. Int. J. Biochem. Cell Biol. 41, 744-747
62. Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J. L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., and Willson, T. M. (1997) Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137-3140
63. Wong, J., Quinn, C. M., and Brown, A. J. (2004) Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol flux. Arterioscler. Thromb. Vasc. Biol. 24, 2365-2371
64. Hong, C., and Tontonoz, P. (2014) Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat. Rev. Drug Discov. 13, 433-444
65. Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J., and Russell, D. W. (2007) Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5, 73-79
66. Zelcer, N., Hong, C., Boyadjian, R., and Tontonoz, P. (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325, 100-104
67. Mandel, H., Sharf, R., Berant, M., Wanders, R. J. A., Vreken, P., and Aviram, M. (1998) Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells. Biochem. Biophys. Res. Commun. 250, 369-373
68. Thai, T. P., Rodemer, C., Jauch, A., Hunziker, A., Moser, A., Gorgas, K., and Just, W. W. (2001) Impaired membrane traffic in defective ether lipid biosynthesis. Hum. Mol. Genet. 10, 127-136
69. Mankidy, R., Ahiahonu, P. W., Ma, H., Jayasinghe, D., Ritchie, S. A., Khan, M. A., Su-Myat, K. K., Wood, P. L., and Goodenowe, D. B. (2010) Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study. Lipids Health Dis. 9, 62
70. Wanders, R. J. A., and Waterham, H. R. (2006) Biochemistry of mammalian peroxisomes revisited. Annu. Rev. Biochem. 75, 295-332
71. Balakrishnan, S., Goodwin, H., and Cumings, J. N. (1961) The distribution of phosphorus-containing lipid compounds in the human brain. J. Neurochem. 8, 276-284
72. Han, X., Holtzman, D. M., and McKeel, D. W., Jr. (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168-1180
73. Hayashi, H. (2011) Lipid metabolism and glial lipoproteins in the central nervous system. Biol. Pharm. Bull. 34, 453-461
74. Nieweg, K., Schaller, H., and Pfrieger, F. W. (2009) Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 109, 125-134
75. Sakakibara, J., Watanabe, R., Kanai, Y., and Ono, T. (1995) Molecular cloning and expression of rat squalene epoxidase. J. Biol. Chem. 270, 17-20